Success Story: Dual NIW & EB1A Success Despite RFE! We Helped A Postdoctoral Associate Get Approval Swiftly with Premium Processing

Client’s Testimonial:

“Amazing news, thank you for your beautiful work putting the application together and addressing the RFE. It has been great working with you.”

On January 25^th, 2025, and August 28^th, 2025, we received another I-140 NIW (National Interest Waiver) and EB1A (Alien of Extraordinary Ability) Approvals for a Postdoctoral Associate in the Field of Biotechnologies (Approval Notice).

General Field: Biotechnologies

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: Hong Kong

State of Residence at the Time of Filing: California

Approval Notice Date: January 25^th, 2025 (NIW) & August 28^th, 2025 (EB1A)

Processing Time: 2 months, 6 days (NIW), and 3 months, 21 days (EB1A) (Premium Processing Requested)

Case Summary:

We are pleased to announce the approval of both an EB-2 National Interest Waiver (NIW) petition and an EB-1A (Individuals with Extraordinary Ability) petition for an outstanding researcher in biotechnology. The NIW was approved in January 2025, and the EB-1A was approved in August 2025, following a successful response to a request for evidence (RFE).

Research Focus and Contributions:
With a Ph.D. in cancer biology, the client has established himself as a leading expert in molecular and cellular biology, genome organization and regulation, cancer cell biology, and cellular signaling. Within biotechnology, he is particularly recognized for advancing the development of CRISPRoff, a novel epigenome editor that expands the frontiers of genome engineering. His pioneering research is shaping new strategies for controlling gene expression with implications for cancer treatment, regenerative medicine, and therapeutic development.

Publications and Citations:
The client has authored 18 peer-reviewed journal articles (5 of them first- or co-first-authored) and 9 abstracts (including 1 first-authored). His research has been cited 1,552 times according to Google Scholar, reflecting the significant impact of his contributions and the reliance of independent researchers on his findings across multiple disciplines in biology and medicine.

Service to the Field:
In addition to his publication record, the client has conducted at least 10 peer reviews for respected journals. His service as a reviewer underscores the recognition of his expertise and his trusted role in guiding the work of fellow scientists.

Funding and Recognition:
The importance of his research is further demonstrated by major funding support from organizations such as the National Institutes of Health (NIH), the National Cancer Institute (NCI), and Cancer Research UK. His achievements have also earned him recognition outside academia, including selection for the prestigious Forbes 30 Under 30 list in the Science category.

Expert Support:
To strengthen the petitions, four recommendation letters were submitted from internationally recognized experts in biotechnology and cancer research. These recommenders emphasized the originality of his methods, the broad applicability of his findings, and the transformative role of his work in advancing genome editing technologies.

“His strong research record also testifies to his exceptional capacity to address critical medical and healthcare challenges, highlighting the value of his ongoing research in the United States.”

NIW & EB1A Approvals and Outlook:
The approvals of both the NIW and EB-1A petitions confirm that the client is not only making research contributions of substantial merit and national importance but has also risen to the very top of his field. With a strong record of publications, high citation impact, peer-review service, prestigious funding, and global recognition, he is exceptionally well-positioned to continue advancing biotechnology and cancer research in the United States.

At NAILG, we congratulate our client on these significant achievements and look forward to his continued impact in the fields of biotechnology and molecular biology.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.